Source: GlobalNewswire

Press Release: Spark Biomedical : Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation

Spark Biomedical unveils the Sparrow® Link Research Platform designed to enable research teams to customize the transcutaneous auricular neurostimulation (tAN) power of the FDA-cleared Sparrow Ascent. Spark Biomedical unveils the Sparrow® Link Research Platform designed to enable research teams to customize the transcutaneous auricular neurostimulation (tAN) power of the FDA-cleared Sparrow Ascent.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Daniel Powell's photo - President & CEO of Spark Biomedical

President & CEO

Daniel Powell

CEO Approval Rating

92/100

Read more